Sequencing Builds Data Bridges to the Clinic
Searching for Innovative, Cost-Effective Product Options
Top 10 Asia Biopharma Clusters 2018
Chinese Economy, Overseas Investment Scrutiny Challenge the East’s Most Promising Regions
Innovations in Viral Clearance
Mock Viruses, Plant Design, and Rational Testing
Improved Assays and Predictive Tools for Drug Lead Optimization
Advanced Strategies to Study Plasma Protein Binding, Improve PK/PD, and Develop Better Enzyme Inhibitors
Andrea Toell Ph.D.
Andrea Toell, Ph.D., is a product manager at Lonza Walkersville. This article is, in part, a summary of the latest advancements in gene editing as discussed at the IBC’s Genome Editing Applications Meeting 2015, which was recently attended by Dr Toell.
More GEN Content From This Contributor
- Feature Articles: A CRISPR Look at Genome Editing
- Tutorials: Genome Editing: An Inside Job
- Feature Articles: Unlocking the Potential of CRISPR-Based Gene Editing